Mitochondrial potential reflects T cell fitness and function during cancer immunotherapy
Paul L Lindau(Vanderbilt University Medical Center), Kathryn E. Beckermann(Vanderbilt University Medical Center), Jonathan M. Irish(Vanderbilt University), Jeffrey C. Rathmell(University of Chicago), Allison E. Sewell(Vanderbilt University Medical Center), Caroline E. Roe(Vanderbilt University), Jackie E. Bader(Vanderbilt University Medical Center), Alex Nesta(International Data Group (Sweden)), W. Kimryn Rathmell(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Zaid Hatem(Vanderbilt University Medical Center), Allison K Blount(Vanderbilt University Medical Center), Reddy Anupama(International Data Group (Sweden)), Madelyn D. Landis(University of Pennsylvania)
Cited by 0
Related Papers
Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell Subsets
|The Journal of Immunology|2011|2k
The Somatic Genomic Landscape of Chromophobe Renal Cell Carcinoma
|Cancer Cell|2014|867
Glucose Uptake Is Limiting in T Cell Activation and Requires CD28-Mediated Akt-Dependent and Independent Pathways
|The Journal of Immunology|2008|836
Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma
|Cancer Cell|2017|791
Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation
|Journal of Clinical Investigation|2014|717